Israeli scientists have had 90% success in their recent experiments to stop cancer metastasis. Their study is focused on treating breast cancer, but they expect the peptide they’ve discovered (a chain of amino acids) will be effective on all tumors.
Approximately 12% of breast cancer patients develop metastatic disease, for which the five-year survival rate is only 26%.
>>Read More: Israeli scientists say substance prevents cancer’s spread in mice with 90% success
